COMPANY
Retham Technologies LLC
Funding and NIH signals
- SEC Form D raise Raised $1.06M (Form D filed Sep 11, 2026). SEC Form D 0002144681-26-000001 (Sep 11, 2026)
Evidence (1 event)
- Sep 11, 2026 · SEC Form D 0002144681-26-000001
Name of Issuer: Retham Technologies, Inc.; CIK: 2144681; Address: Wauwatosa, WI; Submission type: D; Filing date: 2026-09-11; Industry Group: Other; Date of First Sale: 2026-08-28; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 1500000; Total Amount Sold: 1060000; Federal exemptions: 06b
- Sep 11, 2026 · SEC Form D 0002144681-26-000001
- NIH award NIH awarded $1.69M (SBIR Phase II 5R44HL147734-05, continuation, notice Jun 16, 2026). NIH RePORTER 5R44HL147734-05 (Jun 16, 2026)
Evidence (1 event)
- Jun 16, 2026 · NIH RePORTER 5R44HL147734-05
Organization: RETHAM TECHNOLOGIES, INC.; City/State: Wauwatosa, WI; Project number: 5R44HL147734-05; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-06-16; FY total cost (award amount): 1693897; Administering IC: National Heart Lung and Blood Institute; Project title: An in vitro diagnostic assay for the early and accurate detection of platelet-activating antibodies associated with Heparin-inducedThrombocytopenia; Organization type: Domestic For-Profits
- Jun 16, 2026 · NIH RePORTER 5R44HL147734-05
Timeline
- Grant Government grant — SBIR: $1.69M (annual award, as published), announced Jun 16, 2026. Agency: NIH/NHLBI. Source: government award database. source ↗
- Grant Government grant — SBIR: $1.15M (annual award, as published), announced Apr 7, 2025. Agency: NIH/NHLBI. Source: government award database. source ↗
Funding
NIH awards 4
- NIH award 3R44HL147734-03S1 FY2024: $49,399 awarded for that fiscal year; activity R44 (SBIR); PI JONES, CURTIS; recipient as written: RETHAM TECHNOLOGIES, INC., Wauwatosa, WI. An in vitro diagnostic assay for the ea source ↗
- NIH award 5R44HL147734-03 FY2023: $1,220,267 awarded for that fiscal year; activity R44 (SBIR); PI JONES, CURTIS; recipient as written: RETHAM TECHNOLOGIES, INC., Wauwatosa, WI. An in vitro diagnostic assay for the e source ↗
- NIH award 2R44HL147734-02A1 FY2022: $479,730 awarded for that fiscal year; activity R44 (SBIR); PI JONES, CURTIS; recipient as written: RETHAM TECHNOLOGIES, INC., Wauwatosa, WI. An in vitro diagnostic assay for the e source ↗
- NIH award 1R43HL147734-01 FY2019: $224,671 awarded for that fiscal year; activity R43 (SBIR); PI JONES, CURTIS; recipient as written: RETHAM TECHNOLOGIES, INC., Wauwatosa, WI. An in vitro diagnostic assay for the ear source ↗